Amongst known inflammatory markers, cyclooxygenase 2 (COX2, a key enzyme for inflammatory reactions in platelets) expression is increased in mild cognitive impairment (MCI) and AD patients. This evidence concerns the gene PTGS2 and Alzheimer disease.